In RRP, serologic response to HPV is frequently absent and slow to develop-Reference-Cited by-同舟云学术

In RRP, serologic response to HPV is frequently absent and slow to develop

Published:2020-03-11 Issue:3 Volume:15 Page:e0230106
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Buchinsky Farrel J.^ORCID,Ruszkay Nicole,Valentino William^ORCID,Derkay Craig S.,McClay John E.,Bastian Robert W.,Myer Charles M.,Lollar Kevin W.,Guris Dalya

Funder

National Institute on Deafness and Other Communication Disorders

Merck

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Sudden Death Caused by Laryngeal Papillomatosis;J Balažic;Acta Otolaryngol,1997

2. National registry for juvenile-onset recurrent respiratory papillomatosis;WC Reeves;Arch Otolaryngol Head Neck Surg,2003

3. Predictors of remission in juvenile-onset recurrent respiratory papillomatosis;S Ruparelia;Arch Otolaryngol Head Neck Surg,2003

4. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis;MJ Silverberg;Obstet Gynecol,2003

5. The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma;DL Young;J Voice,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Human Papillomavirus Vaccination in Recurrent Respiratory Papilloma Patients Older than 45;The Laryngoscope;2024-02-24

2. Long‐Term Follow‐up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis;The Laryngoscope;2023-02-23

3. The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis;The Laryngoscope;2023-01-18

4. Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis;International Journal of Pediatric Otorhinolaryngology;2022-11

5. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis;JAMA Otolaryngology–Head & Neck Surgery;2022-07-01